These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 31476124)

  • 21. A Fragment-Based Method of Creating Small-Molecule Libraries to Target the Aggregation of Intrinsically Disordered Proteins.
    Joshi P; Chia S; Habchi J; Knowles TP; Dobson CM; Vendruscolo M
    ACS Comb Sci; 2016 Mar; 18(3):144-53. PubMed ID: 26923286
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Identification of new pentapeptides as potential inhibitors of amyloid-β
    Kaur A; Goyal B
    J Mol Graph Model; 2023 Nov; 124():108558. PubMed ID: 37390790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. An α-helix mimetic oligopyridylamide, ADH-31, modulates Aβ
    Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2020 Dec; 22(48):28055-28073. PubMed ID: 33289734
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hydrophobicity and conformational change as mechanistic determinants for nonspecific modulators of amyloid β self-assembly.
    Abelein A; Bolognesi B; Dobson CM; Gräslund A; Lendel C
    Biochemistry; 2012 Jan; 51(1):126-37. PubMed ID: 22133042
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Dissecting the Inhibitory Mechanism of the αB-Crystallin Domain against Aβ
    Xu Z; Gong Y; Zou Y; Wan J; Tang J; Zhan C; Wei G; Zhang Q
    ACS Chem Neurosci; 2022 Oct; 13(19):2842-2851. PubMed ID: 36153964
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Thioflavin T templates amyloid β(1-40) conformation and aggregation pathway.
    Di Carlo MG; Minicozzi V; Foderà V; Militello V; Vetri V; Morante S; Leone M
    Biophys Chem; 2015 Nov; 206():1-11. PubMed ID: 26100600
    [TBL] [Abstract][Full Text] [Related]  

  • 27. 1,2,4-trihydroxynaphthalene-2-O-β-D-glucopyranoside delays amyloid-β
    Dhouafli Z; Leri M; Bucciantini M; Stefani M; Gadhoumi H; Mahjoub B; Ben Jannet H; Guillard J; Ksouri R; Saidani Tounsi M; Soto C; Hayouni EA
    Biofactors; 2018 May; 44(3):272-280. PubMed ID: 29582494
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Understanding amyloid fibril nucleation and aβ oligomer/drug interactions from computer simulations.
    Nguyen P; Derreumaux P
    Acc Chem Res; 2014 Feb; 47(2):603-11. PubMed ID: 24368046
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Curcumin Inhibits the Primary Nucleation of Amyloid-Beta Peptide: A Molecular Dynamics Study.
    Doytchinova I; Atanasova M; Salamanova E; Ivanov S; Dimitrov I
    Biomolecules; 2020 Sep; 10(9):. PubMed ID: 32942739
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Molecular mechanisms of resveratrol and EGCG in the inhibition of Aβ
    Li F; Zhan C; Dong X; Wei G
    Phys Chem Chem Phys; 2021 Sep; 23(34):18843-18854. PubMed ID: 34612422
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding mechanism of inositol stereoisomers to monomers and aggregates of Aβ(16-22).
    Li G; Pomès R
    J Phys Chem B; 2013 Jun; 117(22):6603-13. PubMed ID: 23627280
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determining binding sites of polycyclic aromatic small molecule-based amyloid-beta peptide aggregation modulators using sequence-specific antibodies.
    Irwin JA; Edward Wong H; Kwon I
    Anal Biochem; 2015 Feb; 470():61-70. PubMed ID: 25449301
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Minimalistic Principles for Designing Small Molecules with Multiple Reactivities against Pathological Factors in Dementia.
    Kim M; Kang J; Lee M; Han J; Nam G; Tak E; Kim MS; Lee HJ; Nam E; Park J; Oh SJ; Lee JY; Lee JY; Baik MH; Lim MH
    J Am Chem Soc; 2020 May; 142(18):8183-8193. PubMed ID: 32233474
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Nanodisc-Forming Scaffold Protein Promoted Retardation of Amyloid-Beta Aggregation.
    Sahoo BR; Genjo T; Cox SJ; Stoddard AK; Anantharamaiah GM; Fierke C; Ramamoorthy A
    J Mol Biol; 2018 Oct; 430(21):4230-4244. PubMed ID: 30170005
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Structure-mechanism-based engineering of chemical regulators targeting distinct pathological factors in Alzheimer's disease.
    Beck MW; Derrick JS; Kerr RA; Oh SB; Cho WJ; Lee SJ; Ji Y; Han J; Tehrani ZA; Suh N; Kim S; Larsen SD; Kim KS; Lee JY; Ruotolo BT; Lim MH
    Nat Commun; 2016 Oct; 7():13115. PubMed ID: 27734843
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mechanistic insights into the mitigation of Aβ aggregation and protofibril destabilization by a D-enantiomeric decapeptide rk10.
    Singh K; Kaur A; Goyal D; Goyal B
    Phys Chem Chem Phys; 2022 Sep; 24(36):21975-21994. PubMed ID: 36069400
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Minor Structural Variations of Small Molecules Tune Regulatory Activities toward Pathological Factors in Alzheimer's Disease.
    Beck MW; Derrick JS; Suh JM; Kim M; Korshavn KJ; Kerr RA; Cho WJ; Larsen SD; Ruotolo BT; Ramamoorthy A; Lim MH
    ChemMedChem; 2017 Nov; 12(22):1828-1838. PubMed ID: 28990338
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Amyloid beta: structure, biology and structure-based therapeutic development.
    Chen GF; Xu TH; Yan Y; Zhou YR; Jiang Y; Melcher K; Xu HE
    Acta Pharmacol Sin; 2017 Sep; 38(9):1205-1235. PubMed ID: 28713158
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Mechanism and Kinetics of Amyloid-β
    Man VH; He X; Ji B; Liu S; Xie XQ; Wang J
    ACS Chem Neurosci; 2019 Nov; 10(11):4643-4658. PubMed ID: 31660732
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Edaravone inhibits the conformational transition of amyloid-β42: insights from molecular dynamics simulations.
    Liu F; Ma Z; Sang J; Lu F
    J Biomol Struct Dyn; 2020 May; 38(8):2377-2388. PubMed ID: 31234720
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.